Ovoca Bio Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-3.57	-4.7	-5.61	-5.48	-2.34	-1.57
Depreciation & Amortization	0.18	0.3	0.53	0.08	0.07	0.07
Loss (Gain) From Sale of Assets	-	-	0.31	-	0	-0
Asset Writedown & Restructuring Costs	2.81	4.3	-	-	-	-
Loss (Gain) From Sale of Investments	-	-	0.02	-	-	-
Stock-Based Compensation	-	-	0	0.01	0.01	0.02
Other Operating Activities	0	-	-	-0.1	-0.27	-0.81
Change in Accounts Receivable	0.03	1.1	-0.9	0.08	0.42	-0.11
Change in Inventory	0.03	0.04	0.05	0.18	-0.07	-0.02
Change in Accounts Payable	0.86	0.08	0.43	0.86	0.06	0.24
Change in Other Net Operating Assets	0.07	-	-	-	-	-
Operating Cash Flow	0.4	1.12	-5.16	-4.38	-2.11	-2.17
Capital Expenditures	-	-	-	-0.01	-0.01	-
Sale of Property, Plant & Equipment	-	-	1.2	-	-	0.06
Sale (Purchase) of Intangibles	-0.05	-0.05	-0.04	-0.16	-0.38	-0.63
Investment in Securities	-	-	0.35	-	7.74	11.31
Other Investing Activities	-	-	-	0.1	0.23	0.4
Investing Cash Flow	-0.05	-0.05	1.51	-0.07	7.58	11.13
Long-Term Debt Issued	-	0.04	0.9	-	-	-
Total Debt Issued	0.04	0.04	0.9	-	-	-
Short-Term Debt Repaid	-	-	-	-	-	-0.99
Long-Term Debt Repaid	-	-0.92	-	-	-	-
Total Debt Repaid	-0.92	-0.92	-	-	-	-0.99
Net Debt Issued (Repaid)	-0.88	-0.88	0.9	-	-	-0.99
Other Financing Activities	0.01	-	-	-	-4.09	-
Financing Cash Flow	-0.87	-0.88	0.9	-	-4.09	-0.99
Foreign Exchange Rate Adjustments	0.64	-0.55	-0.13	0.29	-0.65	0.37
Net Cash Flow	0.13	-0.37	-2.89	-4.15	0.73	8.34
Free Cash Flow	0.4	1.12	-5.16	-4.39	-2.12	-2.17
Free Cash Flow Per Share	0.01	0.01	-0.06	-0.05	-0.03	-0.03
Levered Free Cash Flow	0.4	0.06	-2.43	-2.64	-1.34	-1.88
Unlevered Free Cash Flow	0.4	0.06	-2.41	-2.63	-1.33	-1.86

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.